Abstract
Nasal nebulizer has been recognized useful treatment for a long while since 1958. We experienced a case of anaphylactic shock after nasal nebulizer contained cefmenoxime hydrochloride (CMX) and Rinderon. A 58-year-old female had cutaneous symptoms (itching, flush), cardiovascular symptoms (pulse weakening, hypotension), respiratory symptoms (rough breathing, dyspnea), digestive symptoms (vomit, incontinence of anus) and neurological symptom (consciousness loss) after nasal nebulizer. When she has had mild symptoms about anaphylactic reaction before this episode, internal medical doctor had diagnosed that symptoms were suspected neurally mediated syncope. We are recognizing anew difficulty of a precise judgment and speedily handling in face of anaphylactic shock, in spite of understanding possibility of anaphylaxis for antibiotics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
